A: Take one tablet daily with water, preferably at the same time each day, or as directed by your healthcare professional
GLP-1 medications are FDA-approved for chronic weight management in adults with obesity (BMI 30) or overweight (BMI 27-29.9) with at least one weight-related comorbidity
Other therapies were linked to increased adverse events such as stroke [11], hyperkalemia [13,15], hypotension [13], acute kidney injury (AKI) [15], and major adverse cardiovascular events (MACE) [14]
GLP-1 stimulates insulin secretion, suppresses glucagon release, and slows gastric emptying, which collectively help lower blood glucose levels and reduce appetite
Like semaglutide, tirzepatide mimics gut hormones that regulate appetite and blood sugar, but it goes one step further by activating both GIP and GLP-1 receptors
Federal agencies have effectively pulled BPC-157 out of legal circulation, citing the very uncertainties that should give patients and doctors pause